770 related articles for article (PubMed ID: 22318237)
1. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.
Peters JM; Shah YM; Gonzalez FJ
Nat Rev Cancer; 2012 Feb; 12(3):181-95. PubMed ID: 22318237
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.
Laganà AS; Vitale SG; Nigro A; Sofo V; Salmeri FM; Rossetti P; Rapisarda AM; La Vignera S; Condorelli RA; Rizzo G; Buscema M
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347932
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.
Youssef J; Badr M
Br J Pharmacol; 2011 Sep; 164(1):68-82. PubMed ID: 21449912
[TBL] [Abstract][Full Text] [Related]
4. Biology and therapeutic applications of peroxisome proliferator- activated receptors.
Menendez-Gutierrez MP; Roszer T; Ricote M
Curr Top Med Chem; 2012; 12(6):548-84. PubMed ID: 22242855
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.
Monsalve FA; Pyarasani RD; Delgado-Lopez F; Moore-Carrasco R
Mediators Inflamm; 2013; 2013():549627. PubMed ID: 23781121
[TBL] [Abstract][Full Text] [Related]
6. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
Sertznig P; Seifert M; Tilgen W; Reichrath J
J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Brown JD; Plutzky J
Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
[TBL] [Abstract][Full Text] [Related]
8. The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure.
Liao HH; Jia XH; Liu HJ; Yang Z; Tang QZ
Curr Pharm Des; 2017; 23(11):1677-1686. PubMed ID: 27779079
[TBL] [Abstract][Full Text] [Related]
9. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
11. Parsing the Role of PPARs in Macrophage Processes.
Toobian D; Ghosh P; Katkar GD
Front Immunol; 2021; 12():783780. PubMed ID: 35003101
[TBL] [Abstract][Full Text] [Related]
12. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
13. The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics.
Dixit G; Prabhu A
Exp Mol Pathol; 2022 Feb; 124():104723. PubMed ID: 34822814
[TBL] [Abstract][Full Text] [Related]
14. PPARs and Myocardial Infarction.
Wagner KD; Wagner N
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322384
[TBL] [Abstract][Full Text] [Related]
15. The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.
Cheang WS; Tian XY; Wong WT; Huang Y
Br J Pharmacol; 2015 Dec; 172(23):5512-22. PubMed ID: 25438608
[TBL] [Abstract][Full Text] [Related]
16. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.
Mansour M
Prog Mol Biol Transl Sci; 2014; 121():217-66. PubMed ID: 24373239
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
Giaginis C; Tsantili-Kakoulidou A; Theocharis S
Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
[TBL] [Abstract][Full Text] [Related]
18. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
Huang TH; Roufogalis BD
Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
[TBL] [Abstract][Full Text] [Related]
19. PPARs as Nuclear Receptors for Nutrient and Energy Metabolism.
Hong F; Pan S; Guo Y; Xu P; Zhai Y
Molecules; 2019 Jul; 24(14):. PubMed ID: 31336903
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors.
Lu C; Cheng SY
J Mol Endocrinol; 2010 Mar; 44(3):143-54. PubMed ID: 19741045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
